Dexilant

DRUG2 trials

Sponsors

University of Iowa, Genuine Research Center, Egypt

Conditions

Chest PainGastrointestinal Reflux DiseaseHealthy

Phase 1

A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)

CompletedNCT02529787

Genuine Research Center, EgyptHealthy

Start: 2013-02-28End: 2013-03-31Updated: 2015-08-20

Phase 4

Dexilant Treatment in Gastrointestinal Reflux Disease (GERD Related Non Cardiac Chest Pain

WithdrawnNCT01637571

University of IowaChest Pain, Gastrointestinal Reflux Disease

Updated: 2012-07-11